First I believe they will struggle to recruit enough patients especially in Australia.
Second if my memory service me correctly MT stated that the FDA said they don't have to do the trial in the USA
So what's going to happen if they can not get sufficient funds to conduct the phase 2 MND trial, will they plead with option holders to covert their options or face a capital raising.
Big or medium pharmas are not silly so they sit back a wait until pharmaust is in desparate need of cash and make a offer of maybe 20 to 50 cents so shareholders have little option but to accept the offer.
I dont believe there is any real want for canine cancer
Do they have sufficient cash to even start the phase 2 trial
Will it be over 100 days to get an determination on ODD
PAA Price at posting:
30.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)